SHSAX Mutual Fund (BlackRock Health Sciences Opportunity Investor A Class) is managed by BlackRock, Inc. (US) with $2.14B in net assets. SHSAX expense ratio is 1.09%, holding 165 positions across sectors including Health Care, Unknown, Financials. Inception date: 1999-12-21.

SHSAX performance shows a YTD return of -2.72%. The 1-year return is 16.85% and the 5-year return is 4.08%. SHSAX dividend yield stands at 10.92%, paid annually.

SHSAX top holdings include Eli Lilly & Co (11.3%), Johnson & Johnson (10.2%), Abbvie Inc (4.1%), Gilead Sciences Inc (4.0%), Merck & Company Inc (3.5%). View all SHSAX holdings, sector breakdown, or dividend history.

SHSAX can be compared against other funds using the overlap calculator or side-by-side comparison tool. SHSAX alternatives are available via the screener, along with tax-loss harvesting opportunities.